Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Working Memory Maintenance (Expt 2.3)

计划入组 10 人 · 首次发布于 2024 年 12 月 13 日

Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults

首次发布于 2024 年 8 月 22 日

A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

计划入组 3,100 人 · 首次发布于 2023 年 6 月 20 日

XBB-202

XBB.1.5 RBD subunit vaccine

CX-038839 Omicron (XBB.1.5)(Spikevax)

CanSino Biologics Inc.

China

BBB-Therapeutics B.V.

Netherlands

BB Biotech

Switzerland

Novavax COVID-19 Vaccine Receives FDA Emergency Use Authorization for 2023-2024 Formula

FDA Warns Evusheld May Be Ineffective Against COVID-19 Subvariant XBB.1.5

Moderna Submits FDA Application for Updated COVID-19 Vaccine Targeting XBB Variants